World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
27403
World Ranking
13662
National Ranking
6938

Naomi J. Winick publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Naomi J. Winick sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 404 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Naomi J. Winick D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Naomi J. Winick sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Naomi J. Winick is a researcher affiliated with The University of Texas Southwestern Medical Center in the United States. Their work primarily focuses on medical research with a strong emphasis on pediatric oncology and hematology.

The main fields of study for Winick include Medicine, with significant contributions in subfields such as Public Health, Environmental and Occupational Health; Pediatrics, Perinatology and Child Health; Hematology; Oncology; and Pathology and Forensic Medicine.

The scientist's research topics cover various aspects of leukemia and pediatric cancer care, including:

  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Neutropenia and Cancer Infections
  • Adolescent and Pediatric Healthcare

Winick has authored numerous papers, with some recent notable publications including:

  • The genomic landscape of pediatric acute lymphoblastic leukemia, 2022, Nature Genetics
  • Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia, 2020, Journal of Clinical Oncology
  • Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group, 2020, Journal of Clinical Oncology
  • Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children, 2024, New England Journal of Medicine
  • Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932, 2021, Journal of Clinical Oncology

Frequent co-authors collaborating with Winick include Meenakshi Devidas, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz, and William L. Carroll.

Winick's work is commonly published in prominent medical journals and venues such as:

  • Blood
  • Journal of Clinical Oncology
  • Leukemia
  • Pediatric Blood & Cancer
  • JNCI Journal of the National Cancer Institute

Best Publications

  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey

  • Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

    Stephen P. Hunger;Xiaomin Lu;Meenakshi Devidas;Bruce M. Camitta

  • The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    Yu Liu;John Easton;Ying Shao;Jamie Maciaszek

  • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

    Michael J. Borowitz;Meenakshi Devidas;Stephen P. Hunger;W. Paul Bowman;W. Paul Bowman

  • Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

    Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton

  • Factors Influencing Survival After Relapse From Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

    Kim Nguyen;Meenakshi Devidas;Su-Chun Cheng;Mei La

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

    Kirk R. Schultz;D. Jeanette Pullen;Harland N. Sather;Jonathan J. Shuster

  • Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

    K. R. Schultz;A. Carroll;N. A. Heerema;W. P. Bowman

  • Association of CYP3A4 genotype with treatment-related leukemia

    Carolyn A. Felix;Amy H. Walker;Beverly J. Lange;Terence M. Williams

  • Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232

    Eric C. Larsen;Meenakshi Devidas;Si Chen;Wanda L. Salzer

  • Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232

    Michael J. Borowitz;Brent L. Wood;Meenakshi Devidas;Mignon L. Loh

  • Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

    Virginia Perez-Andreu;Kathryn G. Roberts;Richard C. Harvey;Wenjian Yang

  • Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy - A Pediatric Oncology Group study

    D H Mahoney;J J Shuster;R Nitschke;S J Lauer

  • Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.

    N J Winick;R W McKenna;J J Shuster;N R Schneider

  • Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: A report from the children's oncology group

    Wanda L Salzer;Meenakshi Devidas;William L Carroll;Naomi J Winick

  • Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study

    I-Ming Chen;I-Ming Chen;Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;Julie Gastier-Foster;Julie Gastier-Foster;Julie Gastier-Foster

  • Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia

    Jun J. Yang;Cheng Cheng;Meenakshi Devidas;Xueyuan Cao

  • Reinduction platform for children with first marrow relapse in acute lymphoblastic lymphoma

    Elizabeth A. Raetz;Michael J. Borowitz;Meenakshi Devidas;Stephen B. Linda

  • Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

    Barthelemy Diouf;Kristine R. Crews;Glen Lew;Deqing Pei

  • Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations

    Heng Xu;Wenjian Yang;Virginia Perez-Andreu;Meenakshi Devidas

Frequent Co-Authors

Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Meenakshi Devidas
Meenakshi Devidas St. Jude Children's Research Hospital
William L. Carroll
William L. Carroll New York University
Mignon L. Loh
Mignon L. Loh University of California, San Francisco
Elizabeth A. Raetz
Elizabeth A. Raetz New York University
Michael J. Borowitz
Michael J. Borowitz Johns Hopkins University
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Andrew J. Carroll
Andrew J. Carroll University of Alabama at Birmingham
Julie M. Gastier-Foster
Julie M. Gastier-Foster Baylor College of Medicine
Brent L. Wood
Brent L. Wood University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees can expand your opportunities in healthcare and provide flexible pathways to rewarding careers. If you are considering roles beyond becoming a medical doctor, there are several accredited options to advance your education and professional prospects.

For those interested in leadership and advanced clinical practice, you might consider dnp programs without dissertation, which allow busy professionals to earn a terminal nursing degree more efficiently. If you’re looking to enter the workforce quickly, an accelerated lpn program can help you become a licensed practical nurse in a shorter timeframe through online courses combined with clinical experience.

Mental health is an increasingly important field, and the fastest psychiatric nurse practitioner program prepares graduates for highly specialized roles in a matter of months, rather than years. For those leaning towards healthcare administration, pursuing an online health management degree offers a flexible and cost-effective way to advance your career in hospital or clinic management.

Whether you’re looking for speed, affordability, or specialized expertise, these online health degree options provide accessible routes to meaningful careers beyond traditional medical school.

Best Scientists Citing Naomi J. Winick

Trending Scientists

Recently Published Articles